BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 38407266)

  • 21. Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma.
    Walther MM; Reiter R; Keiser HR; Choyke PL; Venzon D; Hurley K; Gnarra JR; Reynolds JC; Glenn GM; Zbar B; Linehan WM
    J Urol; 1999 Sep; 162(3 Pt 1):659-64. PubMed ID: 10458336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical NF1 analysis does not predict NF1 gene mutation status in pheochromocytoma.
    Stenman A; Svahn F; Welander J; Gustavson B; Söderkvist P; Gimm O; Juhlin CC
    Endocr Pathol; 2015 Mar; 26(1):9-14. PubMed ID: 25403449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome.
    Eisenhofer G; Huynh TT; Pacak K; Brouwers FM; Walther MM; Linehan WM; Munson PJ; Mannelli M; Goldstein DS; Elkahloun AG
    Endocr Relat Cancer; 2004 Dec; 11(4):897-911. PubMed ID: 15613462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The genomic landscape of phaeochromocytoma.
    Flynn A; Benn D; Clifton-Bligh R; Robinson B; Trainer AH; James P; Hogg A; Waldeck K; George J; Li J; Fox SB; Gill AJ; McArthur G; Hicks RJ; Tothill RW
    J Pathol; 2015 May; 236(1):78-89. PubMed ID: 25545346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Predictors of Pseudohypoxia-Type Pheochromocytomas.
    Baechle JJ; Smith PM; Ortega CA; Wang TS; Solórzano CC; Kiernan CM
    Ann Surg Oncol; 2022 Jun; 29(6):3536-3546. PubMed ID: 35233740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1.
    Opocher G; Conton P; Schiavi F; Macino B; Mantero F
    Fam Cancer; 2005; 4(1):13-6. PubMed ID: 15883705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional regulation of phenylethanolamine N-methyltransferase in pheochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.
    Huynh TT; Pacak K; Wong DL; Linehan WM; Goldstein DS; Elkahloun AG; Munson PJ; Eisenhofer G
    Ann N Y Acad Sci; 2006 Aug; 1073():241-52. PubMed ID: 17102092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pheochromocytoma and Paraganglioma: From Epidemiology to Clinical Findings.
    Aygun N; Uludag M
    Sisli Etfal Hastan Tip Bul; 2020; 54(2):159-168. PubMed ID: 32617052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical, Biochemical, Tumoural and Mutation Profile of VHL- and MEN2A-Associated Pheochromocytoma: A Comparative Study.
    Dhanda M; Agarwal A; Mandal K; Gupta S; Sabaretnam M; Chand G; Mishra A; Agarwal G; Mishra SK
    World J Surg; 2022 Mar; 46(3):591-599. PubMed ID: 34859295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ErbB-2 induces bilateral adrenal pheochromocytoma formation in mice.
    Lai EW; Rodriguez OC; Aventian M; Cromelin C; Fricke ST; Martiniova L; Lubensky IA; Lisanti MP; Picard KL; Powers JF; Tischler AS; Pacak K; Albanese C
    Cell Cycle; 2007 Aug; 6(15):1946-50. PubMed ID: 17671425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Array-comparative genomic hybridization in sporadic benign pheochromocytomas.
    van Nederveen FH; Korpershoek E; deLeeuw RJ; Verhofstad AA; Lenders JW; Dinjens WN; Lam WL; de Krijger RR
    Endocr Relat Cancer; 2009 Jun; 16(2):505-13. PubMed ID: 19153209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes.
    Gimenez-Roqueplo AP; Dahia PL; Robledo M
    Horm Metab Res; 2012 May; 44(5):328-33. PubMed ID: 22328163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma.
    Pandit R; Khadilkar K; Sarathi V; Kasaliwal R; Goroshi M; Khare S; Nair S; Raghavan V; Dalvi A; Hira P; Fernandes G; Sathe P; Rojekar A; Malhotra G; Bakshi G; Prakash G; Bhansali A; Walia R; Kamalanathan S; Sahoo J; Desai A; Bhagwat N; Mappa P; Rajput R; Chandrashekhar SR; Shivane V; Menon P; Lila A; Bandgar T; Shah N
    Eur J Endocrinol; 2016 Oct; 175(4):311-23. PubMed ID: 27539324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonal patterns in phaeochromocytomas and MEN-2A adrenal medullary hyperplasias: histological and kinetic correlates.
    Diaz-Cano SJ; de Miguel M; Blanes A; Tashjian R; Galera H; Wolfe HJ
    J Pathol; 2000 Oct; 192(2):221-8. PubMed ID: 11004699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of the BRAF V600E mutation in pheochromocytoma.
    Paulsson JO; Svahn F; Welander J; Brunaud L; Söderkvist P; Gimm O; Stenman A; Juhlin CC
    J Endocrinol Invest; 2016 Jun; 39(6):715-6. PubMed ID: 26710756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoter methylation status of Ras-association domain family members in pheochromocytoma.
    Richter AM; Zimmermann T; Haag T; Walesch SK; Dammann RH
    Front Endocrinol (Lausanne); 2015; 6():21. PubMed ID: 25750636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenergic differentiation and Ret expression in rat pheochromocytomas.
    Powers JF; Picard KL; Nyska A; Tischler AS
    Endocr Pathol; 2008; 19(1):9-16. PubMed ID: 18317952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of erythropoietin and its receptor in von hippel-lindau-associated and multiple endocrine neoplasia type 2-associated pheochromocytomas.
    Vogel TW; Brouwers FM; Lubensky IA; Vortmeyer AO; Weil RJ; Walther MM; Oldfield EH; Linehan WM; Pacak K; Zhuang Z
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3747-51. PubMed ID: 15769989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sporadic pheochromocytomas are rarely associated with germline mutations in the vhl tumor suppressor gene or the ret protooncogene.
    Brauch H; Hoeppner W; Jähnig H; Wöhl T; Engelhardt D; Spelsberg F; Ritter MM
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4101-4. PubMed ID: 9398721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GIPC2 is an endocrine-specific tumor suppressor gene for both sporadic and hereditary tumors of RET- and SDHB-, but not VHL-associated clusters of pheochromocytoma/paraganglioma.
    Dong Y; Huang Y; Fan C; Wang L; Zhang R; Li W; Guo Z; Wang D; Zheng Z
    Cell Death Dis; 2021 May; 12(5):444. PubMed ID: 33947839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.